Mar 28, 2024
Advancements in clinical data and research have shown the immunotherapeutic potential of bispecific antibodies as treatment for hematologic cancers and solid tumors. In this episode, CANCER BUZZ speaks with Aaron Cumpston, PharmD, pharmacy clinical specialist for bone marrow transplant and Christine Barrett, PharmD,...
Mar 26, 2024
As the need for access to guideline-concordant biomarker testing for underserved populations continues to grow, hear what care teams need to know about coverage for Medicaid beneficiaries and the legislative outlook for 2024. In this episode, CANCER BUZZ speaks with Hilary Gee Goeckner, MSW, director of State and...
Mar 21, 2024
The ACCC Oncology Reimbursement Meetings (ORMs) help all members of the multidisciplinary cancer care team navigate the annual changes in oncology reimbursement and regulations— while improving their knowledge on effective strategies for success in an everchanging oncology landscape. In this episode, CANCER BUZZ...
Mar 19, 2024
While social determinants of health can impact access to care and treatment options for many patients with cancer, when combined with the complexities of acute myeloid leukemia, these factors become critical to treatment outcomes and quality of life for patients. In this episode, CANCER BUZZ speaks with Linda Hayward,...
Mar 14, 2024
Maintenance therapy for patients with acute myeloid leukemia, particularly those who are ineligible for transplant, can be critical to treatment outcomes and quality of life for patients. In this episode, CANCER BUZZ speaks with Thomas LeBlanc, MD, hematologic oncologist, associate professor of Medicine, and associate...